INCATE
banner
incate.bsky.social
INCATE
@incate.bsky.social
INCATE is an incubator dedicated to combating antimicrobial resistance (AMR). We assist early-stage innovators with advice on R&D and funding, access to a collaborative community, and financial support.
WAAW2025 may be over, but AMR education can’t stop. A new review shows major gaps: few know antibiotics don’t work on viruses. Why do these myths persist, and what really works to improve antibiotic awareness?

Read more ➡️ www.clinicalmicrobiologyandinfection.org/article/S119...
Global and regional knowledge of antibiotic use and resistance among the general public: a systematic review and meta-analysis
Antibiotic resistance threatens effective infection treatment and medical procedures. Global initiatives, such as World AMR Awareness Week, aim to improve public understanding and promote rational ant...
www.clinicalmicrobiologyandinfection.org
November 25, 2025 at 10:23 AM
🚀 Applications for the 2026 AMR Conference Startup Pitch Event are OPEN!
Pitch in Basel, win €10k, and showcase your AMR innovation. Finalists get a free ticket; all applicants get discounts.

Apply now ➡️ www.incate.net/amrconfapply/
November 24, 2025 at 10:04 AM
It’s almost time! Just days away from opening the call for the Pitch Event at the AMR Conference 2026. Get inspired!

2025 - www.youtube.com/watch?v=KN99...

2024 - www.youtube.com/watch?v=IpXz...

2022 - www.youtube.com/watch?v=xgpf...

Get inspired. Be bold. Aim higher.
November 21, 2025 at 7:42 AM
AMR is already reshaping our world — threatening health, economies, and stability. At INCATE, we’re inspired by the ventures pushing bold innovation to fight it. Thank you for your trust and vision. Together, we’re building resilience and a safer future.
November 20, 2025 at 8:45 AM
WAAW 2025: Act Now: Protect Our Present, Secure Our Future.
AMR is rising now—not later. We need stronger surveillance, better access to prevention & diagnostics, sustainable practices, and more innovation + investment.

What can you do today? Let’s act together. And together.
November 18, 2025 at 8:44 AM
Great news, @dzif.bsky.social and KyooBe Tech
November 17, 2025 at 10:24 AM
🚀Registration for the 10th AMR Conference is open!

📍 Basel | 📅 March 3–4, 2026

INCATE supports the Poster Competition (abstracts open!) and the Startup Pitch Event.

Register: amr-conference.com/registration/

Abstracts: amr-conference.com/call-for-abs...

Let’s make Basel the AMR hub again!
November 17, 2025 at 7:46 AM
World Diabetes Day highlights how connected our health challenges are.
People with diabetes face higher infection risks — including from AMR bacteria.

@who.int factsheet ➡️ applications.emro.who.int/docs/WHOEMCS...
November 14, 2025 at 7:35 AM
At #I4ID2025 in Lyon?
Our colleague Derry Mercer from INCATE is there and ready to connect!

Catch him Friday at sessions on Pandemic Preparedness (9:45) and Innovative Biomarkers (3:15).

i4id.org/program/

#AMR #Innovation #InfectiousDiseases
November 13, 2025 at 10:00 AM
🚀 The 10th #AMRConference is coming to Basel!
Submit your poster abstract by Jan 7, 2026 🧫

Showcase your research in #AMR, novel therapies, AI, diagnostics & more!
🏆 Win up to €1,000 + free ticket!

Submit ➡️ amr-conference.com/call-for-abs...

#Science #Basel2026
November 12, 2025 at 7:48 AM
Science saves lives — and today we celebrate it.

On #WorldScienceDay, we’re proud to stand with the innovators fighting #AMR. At INCATE, we help turn bold ideas into real impact.

When science meets entrepreneurship, change happens.

#Innovation #GlobalHealth
November 10, 2025 at 6:00 AM
Biotech founders: small startups are outpacing Big Pharma — 57% of 2023 US drug approvals! Agility, innovation & smart systems make the difference. Are your tools helping you scale fast and stay compliant?

Read more ➡️ buff.ly/dydT1O3

#Biotech #Startups #Innovation
How Biotech Startups Beat Big Pharma at Drug Development
Biotech startups now lead drug approvals in the US. Discover how leaner teams outpace Big Pharma—and why document control is key to their success.
buff.ly
November 8, 2025 at 6:00 AM
FDA has approved Meitheal’s IV fosfomycin (Contepo) for adults with complicated UTIs caused by E. coli and Klebsiella pneumoniae.
It’s the only IV epoxide antibiotic approved in the US.

Read here ➡️ www.businesswire.com/news/home/20...

#Antibiotics #DrugDevelopment
www.businesswire.com
November 6, 2025 at 7:44 AM
Our colleague Peter Seiler is already at #BactiVac in Birmingham!
He’s eager to meet researchers and innovators addressing #AMR through vaccine innovation.
Say hi and learn how INCATE supports impactful vaccine projects!

#VaccineDevelopment
November 5, 2025 at 8:38 AM
Scientists at St. Jude have turned bacterial resistance into a weapon against itself — using a modified florfenicol that activates within drug-resistant M. abscessus. A new frontier in #AMR innovation.

Nature Microbiology ➡️ www.nature.com/articles/s41...
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus - Nature Microbiology
Florfenicol amine hijacks intrinsic resistance in Mycobacterium abscessus, highlighting that antimicrobial resistance mechanisms can be harnessed for antibiotic activation.
www.nature.com
November 4, 2025 at 7:51 AM
It’s #OneHealthDay! At INCATE, we believe tackling #AMR means protecting the health of people, animals & ecosystems together. By supporting innovators, we turn One Health principles into action for a more sustainable, resilient future.
#Innovation #GlobalHealth
November 3, 2025 at 12:00 PM
New research from VUB & VIB shows engineered phages can deliver bacterial toxins to kill drug-resistant E. coli — a precise, promising alternative to antibiotics. A big step forward in tackling AMR!

Read more ➡️ doi.org/10.1128/spec...

#AMR #PhageTherapy #Innovation
Isolation and characterization of bacteriophages from clinical enterohemorrhagic Escherichia coli strains | Microbiology Spectrum
Characterizing bacteriophages from clinical EHEC isolates is crucial in understanding the mechanisms underlying bacterial evolution and virulence. Despite the clinical relevance of EHEC bacteriophages...
doi.org
November 3, 2025 at 7:28 AM
Haven’t seen them yet? WHO released two key AMR reports on antibacterial pipelines & diagnostics — both show urgent innovation gaps.

At INCATE, we’re backing the innovators changing that.

🔗 buff.ly/2VCrGsG

🔗 buff.ly/5Df88Jk

#AMR #Innovation #GlobalHealth
November 1, 2025 at 6:00 AM
Less than a week left! Apply for PACE 2025 Antibacterial Therapeutics funding — up to £1M per project (total £6M).

Open worldwide | Focus: drug-resistant Gram-negative infections.

🗓️ Deadline: 5 Nov, 23:59 UK
➡️ buff.ly/cBfzdLN

#AMR #Innovation #Funding
October 31, 2025 at 6:00 AM
Heading to @bactivac.bsky.social Birmingham next week? INCATE will be there!

Meet our colleague Peter Seiler and learn how INCATE supports vaccine projects tackling AMR. Let’s connect and drive impact together!

#BactiVacEvents #AMR #VaccineDevelopment
October 30, 2025 at 7:28 AM
💥 Our October Newsletter is out! 💥
- INCATE's first report (2021-2024)
- AMR Conference: poster abstract open
- Milestones from the community
🚀 ...and more!

Read all about it in INCATE's Newsletter ➡ lnkd.in/eSp2K9Jv

Haven't you subscribed yet?
Don't fall behind, subscribe here ➡ lnkd.in/dxq4JtMt
October 29, 2025 at 11:21 AM
Reposted by INCATE
🔴 Live TODAY!

Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.

🗓️17:00–18:30 CET

👉 Join here: go.bsky.app/redirect?u=h...

#AMR #Antibiotics #AI #REVIVE
October 28, 2025 at 6:00 AM
Big milestone for INCATE!

Our first report 2021–2024 is out: a journey of bridging academia & industry, supporting ventures, and turning science into impact.

More than a report: a celebration of collaboration, perseverance, and shared purpose.

Read it here ➡️ www.incate.net/celebrating-...
October 28, 2025 at 7:50 AM
Kicking off the week with big news!

Basilea Pharmaceutica is once again sponsoring the Poster Competition at the 10th AMR Conference 2026.

🗓️ Abstracts submission deadline: Jan 7 2026

Info & submission ➡️ amr-conference.com/call-for-abs...
October 27, 2025 at 8:13 AM
Can azithromycin save lives in Africa — without accelerating AMR?
This article explores the dilemma: prevention vs. resistance.
At INCATE, we believe innovation & stewardship must go hand in hand to protect both lives & the antibiotics we rely on.

Read more buff.ly/f6wRu8n

#AMR #GlobalHealth
‘I fear we are sitting on a time bomb.’ Scientists debate mass distribution of antibiotics in Africa
Prophylactic use of azithromycin saves vulnerable children’s lives, but could trigger antibiotic resistance
buff.ly
October 25, 2025 at 5:00 AM